Cargando…

Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively

Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by uncontrolled proliferation of B-cells and severe immune dysfunction. Chemo(immuno)therapies (CIT) have traditionally aimed to reduce tumor burden without fully understanding their effects on the immune system. As a con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno, Carol, Muñoz, Cecilia, Terol, María José, Hernández-Rivas, José-Ángel, Villanueva, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517318/ https://www.ncbi.nlm.nih.gov/pubmed/34654437 http://dx.doi.org/10.1186/s13046-021-02115-1

Ejemplares similares

The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
por: Pérez-Carretero, Claudia, et al.
Publicado: (2021)

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct
por: González-Gascón-y-Marín, Isabel, et al.
Publicado: (2021)

Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2022)

Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study
por: Moreno, Carol, et al.
Publicado: (2023)

Clinical Relevance of +936 C>T VEGFA and c.233C>T bFGF Polymorphisms in Chronic Lymphocytic Leukemia
por: Ballester, Sandra, et al.
Publicado: (2020)

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
por: Quijada‐Álamo, Miguel, et al.
Publicado: (2021)

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions
por: Puiggros, Anna, et al.
Publicado: (2017)

The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When
por: González-Gascón-y-Marín, Isabel, et al.
Publicado: (2023)

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
por: Quijada-Álamo, Miguel, et al.
Publicado: (2021)

Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2023)

Advances in treating chronic lymphocytic leukemia
por: Tausch, Eugen, et al.
Publicado: (2014)

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index
por: Muñoz-Novas, Carolina, et al.
Publicado: (2018)

LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2021)

Venetoclax for treating refractory autoimmune hemolytic anemia in chronic lymphocytic leukemia: report of two cases in Spain
por: Galindo-Navarro, Pablo, et al.
Publicado: (2023)

Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia
por: Xu, Zhao, et al.
Publicado: (2020)

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia
por: Jiménez, Isabel, et al.
Publicado: (2021)

Gallbladder volvulus in a patient with chronic lymphocytic leukemia treated with laparoscopic cholecystectomy
por: Scott, Benjamin B., et al.
Publicado: (2019)

Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14
por: Rodríguez, Ana Eugenia, et al.
Publicado: (2012)

Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways
por: Amigo-Jiménez, Irene, et al.
Publicado: (2015)

Cytoplasmic crystal inclusions in lymphocytes of chronic lymphocytic leukemia
por: Villuendas Vázquez, Òscar, et al.
Publicado: (2020)

Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study
por: Loscertales, Javier, et al.
Publicado: (2023)

Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study
por: Van Den Neste, Eric, et al.
Publicado: (2012)

Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons
por: Rodríguez-Vicente, Ana E., et al.
Publicado: (2017)

Peripheral T-lymphocytes express WNT7A and its restoration in leukemia-derived lymphoblasts inhibits cell proliferation
por: Ochoa-Hernández, Alejandra B, et al.
Publicado: (2012)

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
por: Mato, Anthony R., et al.
Publicado: (2018)

TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
por: Hernández-Sánchez, María, et al.
Publicado: (2014)

Clinical application of obinutuzumab for treating chronic lymphocytic leukemia
por: Luan, Chunyan, et al.
Publicado: (2019)

Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2019)

Refractory chronic lymphocytic leukemia – new therapeutic strategies
por: Schnaiter, Andrea, et al.
Publicado: (2010)

Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
por: Perutelli, Francesca, et al.
Publicado: (2022)

Current and future treatment strategies in chronic lymphocytic leukemia
por: Patel, Krish, et al.
Publicado: (2021)

DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
por: Tsagiopoulou, Maria, et al.
Publicado: (2019)

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
por: Wang, Yucai, et al.
Publicado: (2021)

Recognizing acute promyelocytic leukemia in a patient with treated chronic lymphocytic leukemia
por: Nanua, Suparna, et al.
Publicado: (2020)

Diffuse pulmonary infiltrates in an old man with chronic lymphocytic leukemia
por: Hosseinnezhad, Alireza, et al.
Publicado: (2011)

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia
por: Villa-Álvarez, Mónica, et al.
Publicado: (2018)

A review of the incidence of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax and debulking strategies
por: Sharman, Jeffrey P., et al.
Publicado: (2022)

Practical Management of the Venetoclax-Treated Patient in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
por: Waggoner, Matthew, et al.
Publicado: (2022)

A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia
por: Hernández, José Ángel, et al.
Publicado: (2015)

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
por: Quijada-Álamo, Miguel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6qae841edv70l6kp5p1hdq6una